 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- cyclophosphamide / Generic mfg., methotrexate / Generic mfg., cyclosporine / Generic mfg.
DR-01, a Non-Fucosylated Anti-CD94 Antibody, Depletes Leukemic Cells in Ex Vivo and In Vivo Models of Large Granular Lymphocyte Leukemia (ENMCC - 391-392) - Nov 4, 2022 - Abstract #ASH2022ASH_5347;
Additional profiling and evaluation of DR-01 in LGLL patient samples ex vivo as part of a pre-phase I study is ongoing. A phase I/II trial has been initiated to assess the safety and efficacy of DR-01 in previously treated LGLL patients.
- | DR-01 / Dren Bio
New P1/2 trial: A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas (clinicaltrials.gov) - Jul 27, 2022
P1/2, N=69, Recruiting, Sponsor: Dren Bio